|
|||
Recherche
1.
Transgene and Jennerex Announce First Patient Treated in Phase 1/2 Clinical Trial of JX594/TG6006 in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer
(100% Alsace - BUZZ/L'Alsace jour après jour)
... trial of JX594 in patients with whose metastatic colorectal cancer has become refractory to... Retrouvez tout l'article Transgene and Jennerex Announce First Patient Treated in Phase 1/2 Clinical Trial ...
Mercredi, 21 Mars 2012
|
|
||